CsPbBr-PbSBr Janus nanocrystals (NCs) are the only nanomaterial where the epitaxial structure of perovskite and chalcogenide materials has been realized at the nanoscale, but their exciton dynamics mechanism has not yet been thoroughly investigated or applied in photodetection applications. This work reports an attractive device performance of perovskite photoconductors based on epitaxial CsPbBr-PbSBr Janus NCs, as well as the carrier relaxation and transfer mechanism of the heterojunction. By a combination of transient optical absorption and quantum dynamics simulation, it is demonstrated that the photogenerated holes on CsPbBr can be successfully extracted by PbSBr, while the hole transfer proceeds about three times faster than energy loss and remains "hot" for about 300 fs. This feature has favorable effects on long-range charge separation and transport; therefore, the Janus NCs photoconductors exhibit an exceptional responsivity of 34.0 A W and specific detectivity of 1.26 × 10 Jones.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acs.jpclett.3c00198 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Synthesis and performance analysis of novel SiO Janus nanoparticles for enhancing gas foam injection in oil reservoirs.
Sci Rep
January 2025
Faculty of Chemical Engineering, Tarbiat Modares University, Tehran, Iran.
Gas foam injection offers a viable solution to challenges faced in oil reservoirs, yet ensuring optimal foamability and stability remains a pivotal hurdle in practical field operations. This study presents a novel synthesis procedure to create silica (SiO) Janus nanoparticles (JNPs) and examines their potential to enhance gas foam stability for enhanced oil recovery (EOR) applications. Two variations of SiO JNPs were synthesized via a masking procedure, employing oleic acid and ascorbic acid within a Pickering emulsion, marking a pioneering approach.
View Article and Find Full Text PDFTofacitinib in focus: Fascinating voyage from conventional formulations to novel delivery systems.
Int J Pharm
January 2025
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKMs NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, Maharashtra 400056, India. Electronic address:
Tofacitinib, a Janus kinase (JAK) inhibitor, has emerged as a primary therapeutic agent for managing autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, dermatitis and ulcerative colitis. By inhibiting the phosphorylation of JAK enzymes, tofacitinib prevents their activation within the JAK-STAT signaling pathway, which is vital for inflammatory responses. However, the tofacitinib delivery presents significant challenges, including pH-dependent solubility, poor permeability and susceptibility to oral degradation.
View Article and Find Full Text PDFJanus Protein Nanoparticles Tailoring Bicontinuous Aerogels for Efficient Heavy Metal Ion Absorption.
Small
January 2025
School of Food Science and Technology, Jiangnan University, Wuxi, 21422, China.
Bicontinuous structures are exquisite interpenetrating constructs with an optimal balance between connectivity and surface area. Such unique geometry favors exceptional mechanical properties and efficient inward mass diffusion essential for an absorbent material. Although bicontinuous structures are found across many length scales in nature, synthesizing artificial analogs using biological building blocks remains largely unexplored.
View Article and Find Full Text PDFExploring mimosamycin as a Janus kinase 2 inhibitor: A combined computational and experimental investigation.
Comput Biol Chem
January 2025
Center of Excellence in Structural and Computational Biology, Department of Biochemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand; Program in Bioinformatics and Computational Biology, Graduate School, Chulalongkorn University, Bangkok 10330, Thailand. Electronic address:
Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play a crucial role in signal transduction pathways. JAK2 has been implicated in the pathogenesis of leukemia, making it a promising target for research aimed at reducing the risk of this disease. This study examined the potential of mimosamycin as a JAK2 inhibitor using both in vitro and in silico approaches.
View Article and Find Full Text PDFHarnessing defective interfering particles and lipid nanoparticles for effective delivery of an anti-dengue virus RNA therapy.
Mol Ther Nucleic Acids
March 2025
Program of Infection and Inflammation, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
Currently, no approved antiviral drugs target dengue virus (DENV) infection, leaving treatment reliant on supportive care. DENV vaccine efficacy varies depending on the vaccine type, the circulating serotype, and vaccine coverage. We investigated defective interfering particles (DIPs) and lipid nanoparticles (LNPs) to deliver DI290, an anti-DENV DI RNA.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!